Gestational Diabetes: A Field of Controversy

Obstetrical and Gynecological Survey

Volumn 58, Issue 11, 2003, Pages 759-769

  Vidaeff, Alex C ^a   Yeomans, Edward R ^a   Ramin, Susan M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE INTOLERANCE; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PREGNANCY; HUMAN; INSULIN RESISTANCE; MACROSOMIA; MASS SCREENING; MATERNAL MORBIDITY; METHODOLOGY; PATHOPHYSIOLOGY; PERINATAL MORBIDITY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREVALENCE; REVIEW; SCREENING;

DIABETES, GESTATIONAL; FEMALE; HUMANS; MASS SCREENING; PREGNANCY;

EID: 0242267537     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OGX.0000093782.25261.AC     Document Type: Review

References (95)

1. Summary and recommendations. First international workshop-conference on gestational diabetes mellitus. Diabetes Care 1980;3:499-501
2. Hadden DR. A historical perspective on gestational diabetes. Diabetes Care 1998;21(suppl 2):B3-B4
3. Miller HC. The effect of the prediabetic state on the survival of the fetus and the birth weight of the newborn infant. N Engl J Med 1945;233:376-378
4. Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol 1954;16:330-342
5. Jackson WPU, Studies in pre-diabetes. Br Med J 1952;2:690-696
6. Hunter DJ, Milner R. Gestational diabetes and birth trauma (letter). Am J Obstet Gynecol 1985;152:918-919
7. Tuffnell DJ, West J, Walkinshaw SA. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy (review). Cochrane Database Syst Rev 2003;3:CD003395
8. Brody SC, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003;101:380-392
9. Young TK, Mustard CA. Undiagnosed diabetes: Does it matter? CMAJ 2001;164:24-28
10. O'Sullivan JB, Charles D, Mahan CM, et al. Gestational diabetes and perinatal mortality rate. Am J Obstet Gynecol 1973;116:901-904
11. Cousins L. Pregnancy complications among diabetic women: review 1965-1985. Obstet Gynecol Surv 1987:42:140-149
12. Kinnala A, Rikalainen H, Lapinleimu H, et al. Cerebral magnetic resonance imaging and ultrasonography findings after neonatal hypoglycemia. Pediatrics 1999;103:724-729
13. Gabbe SG, Mestman JG, Freeman RK, et al. Management and outcome of class A diabetes mellitus. Am J Obstet Gynecol 1977;127:465-469
14. Mimouni F, Miodovnik M, Siddiqi TA, et al. Perinatal asphyxia in infants of insulin-dependent diabetic mothers. J Pediatr 1988;113:345-353
15. Widness JA, Susa JB, Garcia JF, et al. Increased erythropoiesis and elevated erythropoietin in infants of diabetic mothers and in hyperinsulinemic rhesus fetuses. J Clin Invest 1981;67:637-642
16. Salvesen DR, Brudenell JM, Snijders RJM, et al. Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 1993;168:88-94
17. Yeruchimovich M, Mimouni FB, Green DW, et al. Nucleated red blood cells in healthy infants of women with gestational diabetes. Obstet Gynecol 2000;95:84-86
18. Rust OA, Bofill JA, Andrew ME, et al. Lowering the threshold for diagnosis of gestational diabetes. Am J Obstet Gynecol 1996;175:961-965
19. Casey BM, Lucas MJ, McIntire DD, et al. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 1997;90:869-873
20. Sermer M, Naylor CD, Farine D, et al, for the Toronto Tri-Hospital Gestational Diabetes Investigators. The Toronto Tri-Hospital Gestational Diabetes Project: a preliminary review. Diabetes Care 1998;21:B33-B42
21. Neigher R. Fetal macrosomia in the diabetic patient. Clin Obstet Gynecol 1992;35:138-150
22. Fraser R. Diabetic control in pregnancy and intrauterine growth of the fetus. Br J Obstet Gynaecol 1995;102:3-5
23. Boyd ME, Usher RH, McLean FH. Fetal macrosomia: Prediction, risks, proposed management. Obstet Gynecol 1983;61:715-722
24. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S. 1990-1998. Diabetes Care 2000;23:1278-1283
25. Catalano PM, Vargo KM, Bernstein IM, et al. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 1991;165:914-919
26. Pettitt DJ, Bennett PH, Knowler WC, et al. Gestational diabetes mellitus and impaired glucose tolerance during pregnancy, Long-term effects on obesity and glucose tolerance in the offspring. Diabetes 1985;34(suppl 2):119-122
27. Proceedings of the Second International Workshop-Conference on Gestational Diabetes Mellitus. October 25-27, 1984, Chicago, IL. Diabetes 1985;34(suppl 2):123-126
28. Gaudier FL, Hauth JC, Poist M, et al, Recurrence of gestational diabetes mellitus. Obstet Gynecol 1992;80:75-78
29. Metzger BE, Coustan DR, Organizing Committee. Summary and recommendations of the fourth international workshop-conference on gestational diabetes. Diabetes Care 1998;21(suppl 2):B161-B167
30. Major CA, de Veciana M, Weeks J, et al. Recurrence of gestational diabetes: Who is at risk? Am J Obstet Gynecol 1998;179:1038-1042
31. Engelgau MM, Herman WH, Smith PJ, et al. The epidemiology of diabetes and pregnancy in the US, 1988. Diabetes Care 1995;18:1029-1033
32. Coustan DR, Nelson C, Carpenter MW, et al. Maternal age and screening for gestational diabetes: A population-based study. Obstet Gynecol 1989;73:557-561
33. Khine ML, Winklestein A, Copel JA. Selective screening for gestational diabetes mellitus in adolescent pregnancies. Obstet Gynecol 1999;93:738-742
34. Egeland GM, Skjaerven R, Irgens LA. Birth characteristics of women who develop gestational diabetes: population based study. BMJ 2000;321:546-547
35. Plante LA. Small size at birth and later diabetic pregnancy. Obstet Gynecol 1998;92:781-784
36. Barker DJP, Hales CN, Fall CHD, et al. Type 2(non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): Relation to reduced fetal growth. Diabetologia 1993;36:62-67
37. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197
38. Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1992 update: 1. Screening for gestational diabetes mellitus. CMAJ 1992;147:435-443
39. Moses RG, Moses J, Davis WS. Gestational diabetes: do lean young Caucasian women need to be tested? Diabetes Care 1998;21:1803-1806
40. American College of Obstetricians and Gynecologists. Gestational diabetes. ACOG practice bulletin no. 30. Washington, DC: American College of Obstetricians and Gynecologists, 2001.
41. Wilkerson HLC, Remein QR. Studies of abnormal carbohydrate metabolism in pregnancy. Diabetes 1957;6:324-329
42. O'Sullivan JB, Mahan CM, Charles D, et al. Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 1973;116:895-900
43. Coustan DR, Widness JA, Carpenter MW, et al. Should the fifty-gram one-hour plasma glucose screening test for gestational diabetes be administered in the fasting or fed state? Am J Obstet Gynecol 1986;154:1031-1035
44. Lind T. Antenatal screening using random blood glucose values. Diabetes 1985;34(suppl 2):17-20
45. Cousins L, Dattel BJ, Hollingsworth DR, et al. Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy. Am J Obstet Gynecol 1984;150:455-460
46. Ryan EA, Stark R, Crockford PM, et al. Assessment of value of glycosylated albumin and protein in detection of gestational diabetes. Diabetes Care 1987;10:213-216
47. Weiner CP, Fraser MM, Burns JM, et al. Cost efficacy of routine screening for diabetes in pregnancy: 1-h versus 2-h specimen. Diabetes Care 1986;9:255-259
48. Landy HJ, Gomez-Marin O, O'Sullivan MJ. Diagnosing gestational diabetes mellitus: Use of glucose screen without administering the glucose tolerance test. Obstet Gynecol 1996;87:395-400
49. Shivvers SA, Lucas MJ. Gestational diabetes. Is a 50-g screening result ≥200 mg/dL diagnostic? J Reprod Med 1999;44:685-688
50. Benjamin F, Wilson SJ, Deutsch S, et al. Effect of advancing pregnancy on the glucose tolerance test and on the 50-g glucose load screening test for gestational diabetes. Obstet Gynecol 1986;68:362-365
51. Mochizuki M. Studies on human placental lactogen. Acta Obstet Gynecol Jpn 1973;25:1043-1047
52. Jovanovic L, Peterson CM. Screening for gestational diabetes: optimum timing and criteria for retesting. Diabetes 1985;34(suppl 2):21-23
53. Lin CC, River J, River P, et al. Good diabetic control early in pregnancy and favorable fetal outcome. Obstet Gynecol 1986;67:51-56
54. Wein P, Dong ZG, Beisher NA, et al. Factors predictive of recurrent gestational diabetes diagnosed before 24 weeks gestation. Am J Perinatol 1995;12:352-356
55. Sacks DA, Abu-Fadil S, Karten GJ, et al. Screening for gestational diabetes with the one-hour 50-g glucose test. Obstet Gynecol 1987;70:89-93
56. Jaffe GM, Esterlitz JR, Levine RJ, et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Am J Obstet Gynecol 1998;179:1032-1037
57. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-1057
58. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-773
59. O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13:278-285
60. Langer O, Anyaegbunam A, Brustman L, et al. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 1989;161:593-599
61. Neiger R, Coustan DR. The role of repeat glucose tolerance tests in the diagnosis of gestational diabetes. Am J Obstet Gynecol 1991;165:787-790
62. Schaefer-Graf UM, Rossi R, Buhrer C, et al. Rate and risk factors of hypoglycemia in large-for-gestational-age newborn infants of nondiabetic mothers. Am J Obstet Gynecol 2002;187:913-917
63. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications, Geneva: World Health Organization; 1999
64. Coustan DR, Carpenter MW. The diagnosis of gestational diabetes. Diabetes Care 1998;21(suppl 2):B5-B8
65. Lind T, Phillips PR, the DPSG of the EASD. Influence of pregnancy on the 75-g OGTT: a prospective multicenter study. Diabetes 1991;40(suppl 2):8-13
66. Harlass FE, Brady K, Read JA. Reproducibility of the oral glucose tolerance test in pregnancy. Am J Obstet Gynecol 1991;164:564-568
67. Leturque A, Ferre P, Burnol AF, et al. Glucose utilization rates and insulin sensitivity in vivo in tissue of virgin and pregnant rats. Diabetes 1986;35:172-177
68. Hu FB, Stampfer MJ, Solomon C, et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 2001;134:96-105
69. McFarland MB, Langer O, Conway DL, et al. Dietary therapy for gestational diabetes: How long is long enough? Obstet Gynecol 1999;93:978-982
70. Thompson DJ, Porter KB, Gunnells DJ, et al. Prophylactic insulin in the management of gestational diabetes. Obstet Gynecol 1990;75:960-964
71. Langer O, Rodriguez DA, Xenakis EM, et al. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 1994;170:1046-1047
72. Langer O, Kozlowski S, Brustman L. Abnormal growth patterns in diabetes in pregnancy: A longitudinal study. Israel J Med Sci 1991;27:516-523
73. Kjos SL, Schaefer-Graf U, Sardesi S, et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 2001;24:1904-1910
74. Menon RK, Cohen RM, Sperling MA, et al. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus: its role in fetal macrosomia. N Engl J Med 1990;323:309-315
75. Jovanovic-Peterson L, Kitzmiller JL, Peterson CM. Randomized trial of human versus animal species insulin in diabetic pregnant women: Improved glycemic control, not fewer antibodies to insulin, influences birth weight. Am J Obstet Gynecol 1992;167:1325-1330
76. Akre PR, Kirtley WR, Galloway JA. Comparative hypoglycemic response of diabetic subjects to human insulin or structurally similar insulins of animal source. Diabetes 1964;13:135-143
77. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 1998;21(suppl 1):S60-S61
78. Sutherland HW, Stowers JM, Cormack JD, et al. Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy. BMJ 1973;3:9-13
79. Notelovitz M. Sulphonylurea therapy in the treatment of the pregnant diabetic. S Afr Med J 1971;45:226-229
80. Coetzee EJ, Jackson WP, The management of non-insulin dependent diabetes during pregnancy. Diabetes Res Clin Pract 1986;1:281-287
81. Coetzee EJ, Jackson WP. Metformin in management of pregnant insulin-independent diabetics. Diabetologia 1979;16:241-245
82. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med 2000;17:507-511
83. Nestler JE, Jakubowicz DJ, Evans WS, et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998;338:1876-1880
84. Batukan C, Baysal B. Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2001;265:124-127
85. De Leo V, la Marca A, Ditto A, et al. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 1999;72:282-285
86. Stadtmauer LA, Toma SK, Riehl RM, et al. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 2001;75:505-509
87. Glueck CJ, Phillips H, Cameron D, et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001;75:46-52
88. Glueck CJ, Wang P, Kobayashi S, et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002;77:520-525
89. Mikola M, Hiilesmaa V, Halttunen M, et al. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001;16:226-229
90. Elliott BD, Langer O, Schenker S, et al. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991;165:807-812
91. Elliott BD, Schenker S, Langer O, et al. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 1994;171:653-660
92. Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-1138
93. Zarate A, Ochoa R, Hernandez M, et al. Effectiveness of acarbose in the control of glucose tolerance worsening in pregnancy. Ginecol Obstet Mex 2000;68:42-45
94. Hellmuth E, Damm P, Molsted-Pedersen L. Congenital malformations in offspring of diabetic women treated with oral hypoglycaemic agents during embryogenesis. Diabet Med 1994;11:471-474
95. Sjogren B, Robeus N, Hansson U. Gestational diabetes: a case-control study of women's experience of pregnancy, health and the child. J Psychosom Res 1994;38:815-822